Avricore Health (AVCRF) Cash from Operations (2014 - 2025)

Avricore Health has disclosed Cash from Operations across 12 years of filings, most recently posting 358560.22 for Q3 2025.

• In Q3 2025, Cash from Operations fell 174.35% year-over-year to 358560.22; the TTM figure through Sep 2025 stood at 140771.22 (down 88.92% YoY), while the FY2025 annual figure was 565371.98, down 177.05% from the prior year.
• Cash from Operations slipped to 358560.22 in Q3 2025, from 135853.72 in the prior quarter.
• Over the last five years, Cash from Operations for AVCRF reached as high as 482253.11 in Q3 2024 and fell as low as 358560.22 in Q3 2025.
• The 5-year median for Cash from Operations is 1341.79 (2022), against an average of 5164.32.
• Annual changes were most pronounced in 2023 — Cash from Operations jumped 1118.76% — and 2025, when it tumbled 174.35%.
• A 5-year view of Cash from Operations shows it stood at 217428.03 in 2021, then jumped by 91.78% to 17881.25 in 2022, then jumped by 1118.76% to 182167.01 in 2023, then soared by 164.73% to 482253.11 in 2024, then plunged by 174.35% to 358560.22 in 2025.
• According to Business Quant data, Cash from Operations over the past three periods registered 358560.22, 135853.72, and 152932.05 for Q3 2025, Q2 2025, and Q1 2025 respectively.